Expanding the clinical and phenotypic heterogeneity associated with biallelic variants in <i>ACO2</i>
Patrick R. Blackburn(St. Jude Children's Research Hospital), Brendan C. Lanpher(Vanderbilt University), Deborah L. Renaud(Mayo Clinic in Florida), Amy Kenney(Children's Hospital of The King's Daughters), Carrie A. Lahner(Mayo Clinic), Linda Hasadsri(Mayo Clinic in Arizona), Fowzan S. Alkuraya(Alfaisal University), Matthew Schultz(Mayo Clinic in Arizona), Elizabeth Bhoj(Children's Hospital of Philadelphia), Dong Li(Children's Hospital of Philadelphia), Niema Ibrahim(King Faisal Specialist Hospital & Research Centre), Mohammed Zain Seidahmed(Security Forces Hospital), Laura J. Fisher(Mayo Clinic), Samantha A. Schrier Vergano(Children's Hospital of The King's Daughters)
Cited by 18
Related Papers
SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment
|Blood|2008|345
Mutations in PDGFRB Cause Autosomal-Dominant Infantile Myofibromatosis
|The American Journal of Human Genetics|2013|206
<i>SUMO1</i> Haploinsufficiency Leads to Cleft Lip and Palate
|Science|2006|193
GRIN2D Recurrent De Novo Dominant Mutation Causes a Severe Epileptic Encephalopathy Treatable with NMDA Receptor Channel Blockers
|The American Journal of Human Genetics|2016|183